These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1000706)

  • 41. [Current treatment of the Parkinsonian syndrome].
    Voiculescu V
    Neurol Psihiatr Neurochir; 1973; 18(6):519-23. PubMed ID: 4790485
    [No Abstract]   [Full Text] [Related]  

  • 42. [Trial use of L-dopa associated with a dopa-decarboxylase inhibitor in Parkinson's syndrome].
    Carotti A; Tomassetti G; Lucciarini L; Barone G; Mugnai A
    Clin Ter; 1974 Jul; 70(1):9-15. PubMed ID: 4153252
    [No Abstract]   [Full Text] [Related]  

  • 43. [Catecholamine excretion and treatment of parkinsonism with midantan].
    Kandel' EI; Iadgarov IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
    [No Abstract]   [Full Text] [Related]  

  • 44. Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations.
    Furukawa Y; Filiano JJ; Kish SJ
    Mov Disord; 2004 Oct; 19(10):1256-8. PubMed ID: 15389992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Drug treatment of hyperkinesis and mental changes caused by levodopa].
    Presthus J
    Tidsskr Nor Laegeforen; 1975 Jun; 95(16):1009-10. PubMed ID: 1145574
    [No Abstract]   [Full Text] [Related]  

  • 46. Dystonia induced by combined treatment with L-dopa and MK-801 in parkinsonian monkeys.
    Rupniak NM; Boyce S; Steventon MJ; Iversen SD; Marsden CD
    Ann Neurol; 1992 Jul; 32(1):103-5. PubMed ID: 1642462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Letter: Electroconvulsive therapy in patients with parkinsonism.
    Lipper S; Bermanzohn PC
    Am J Psychiatry; 1975 Apr; 132(4):457. PubMed ID: 1119602
    [No Abstract]   [Full Text] [Related]  

  • 48. Parkinson's disease: drug therapy.
    Oertel WH; Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):89-108. PubMed ID: 9426870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent developments in the treatment of Parkinson's disease.
    Greer M
    Geriatrics; 1985 Feb; 40(2):34-8, 41. PubMed ID: 2857148
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of Parkinsonian syndrome using amantadine hydrochloride].
    Schubert U; Fischer GJ; Glass J
    Z Arztl Fortbild (Jena); 1975 May; 69(9):469-76. PubMed ID: 1106004
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical aspects and pathogenesis of the "on-off" phenomenon in Parkinson syndrome].
    Jörg J; Schneider I
    Fortschr Neurol Psychiatr; 1988 Jan; 56(1):22-34. PubMed ID: 3126121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of amantadine on neuroleptic-induced parkinsonism.
    Rüther E; Fussmann-Hegewald M; Eben E
    Act Nerv Super (Praha); 1973 May; 15(2):93. PubMed ID: 4148089
    [No Abstract]   [Full Text] [Related]  

  • 54. L-tryptophan in the treatment of levodopa induced psychiatric disorders.
    Miller EM; Nieburg HA
    Dis Nerv Syst; 1974 Jan; 35(1):20-3. PubMed ID: 17894051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].
    Cinca I; Serbănescu A; Tudorache B
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1982; 27(4):261-70. PubMed ID: 6222452
    [No Abstract]   [Full Text] [Related]  

  • 56. [Amantadine in the therapy of Parkinson syndromes].
    Pfaff G
    Med Klin; 1980 Oct; 75(22):792-4. PubMed ID: 7453628
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term effects of L-dopa and procyclidine on neuroleptic-induced extrapyramidal and schizophrenic symptoms.
    Chouinard G; Annable L; Mercier P; Turnier L
    Psychopharmacol Bull; 1987; 23(1):221-6. PubMed ID: 2885889
    [No Abstract]   [Full Text] [Related]  

  • 58. Levodopa and amantadine in the treatment of Parkinsonism.
    Critchley E
    Practitioner; 1972 Apr; 208(246):499-504. PubMed ID: 5031037
    [No Abstract]   [Full Text] [Related]  

  • 59. Drugs for parkinsonism.
    Med Lett Drugs Ther; 1986 Jun; 28(716):62-4. PubMed ID: 3713639
    [No Abstract]   [Full Text] [Related]  

  • 60. [Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease].
    Cersósimo MG; Scorticati MC; Micheli FE
    Medicina (B Aires); 2000; 60(3):321-5. PubMed ID: 11050808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.